IFNA1 and Alzheimer disease: Beyond studies of mouse models and post-mortem AD brain tissue, recent integrative analyses of human genetic data and microglial transcriptomic data have suggested that variation in OAS1, an established IFN response gene, may modify risk for AD (14, 15).